Fessler R D, Sobel J, Guyot L, Crane L, Vazquez J, Szuba M J, Diaz F G
Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Feb 1;17(2):137-42. doi: 10.1097/00042560-199802010-00006.
The most important predictor of early mortality in patients with HIV-associated cryptococcal meningitis is mental status at presentation; patients who present with altered mental status have up to 25% mortality. Historically, cerebrospinal fluid (CSF) diversion in HIV-negative patients with cryptococcal meningitis and signs of elevated intracranial pressure (ICP) has improved survival. In an effort to affect survival and morbidity rates in patients with HIV-associated cryptococcal meningitis, we have initiated aggressive management of elevated ICP in patients with focal neurologic deficits, mental obtundation, or both.
We identified 10 patients with HIV-associated cryptococcal meningitis who presented with symptoms consistent with elevated ICP, including headache, mental obtundation, papilledema, and cranial nerve palsies. Elevated opening pressure was defined as > 20 cm CSF during lumbar puncture. In patients with elevated opening pressures who had focal neurologic deficits or mental status changes refractory to serial lumbar puncture, management consisted of immediate placement of lumbar drains for continuous drainage of CSF to maintain normal ICP (10 cm CSF). Patients with persistent elevations of spinal neuraxis pressure following lumbar drainage underwent placement of lumbar peritoneal shunts.
All patients returned to their baseline level of consciousness following normalization of ICP. Two patients were weaned from lumbar drainage. Eight patients eventually required placement of lumbar peritoneal shunts for persistently elevated ICP despite successful antifungal therapy. Follow-up ranged from 1 to 15 months. One shunt infection occurred, one lumbar peritoneal shunt was converted to a ventriculoperitoneal shunt, and one shunt was removed.
Elevated ICP in patients with HIV-associated cryptococcal meningitis is a significant source of morbidity and mortality. The use of lumbar drainage and selective placement of lumbar peritoneal shunts in the management of elevated ICP in patients with HIV-associated cryptococcal meningitis can ameliorate the sequelae of elevated ICP.
HIV 相关隐球菌性脑膜炎患者早期死亡的最重要预测因素是就诊时的精神状态;出现精神状态改变的患者死亡率高达 25%。从历史上看,对于患有隐球菌性脑膜炎且有颅内压(ICP)升高迹象的 HIV 阴性患者,脑脊液(CSF)分流可提高生存率。为了影响 HIV 相关隐球菌性脑膜炎患者的生存率和发病率,我们对出现局灶性神经功能缺损、精神迟钝或两者皆有的患者的 ICP 升高进行了积极管理。
我们确定了 10 例 HIV 相关隐球菌性脑膜炎患者,他们出现了与 ICP 升高相符的症状,包括头痛、精神迟钝、视乳头水肿和颅神经麻痹。腰穿时开放压升高定义为>20 cm 脑脊液。对于开放压升高且有局灶性神经功能缺损或经多次腰穿后精神状态改变难以缓解的患者,治疗包括立即放置腰大池引流管以持续引流脑脊液,以维持正常 ICP(10 cm 脑脊液)。腰大池引流后脊髓神经轴压力持续升高的患者接受了腰大池-腹腔分流术。
所有患者在 ICP 恢复正常后均恢复到基线意识水平。2 例患者停止了腰大池引流。8 例患者尽管抗真菌治疗成功,但最终因 ICP 持续升高而需要放置腰大池-腹腔分流术。随访时间为 1 至 15 个月。发生了 1 例分流感染,1 例腰大池-腹腔分流术改为脑室-腹腔分流术,1 例分流管被移除。
HIV 相关隐球菌性脑膜炎患者的 ICP 升高是发病率和死亡率的重要来源。在 HIV 相关隐球菌性脑膜炎患者的 ICP 升高管理中使用腰大池引流和选择性放置腰大池-腹腔分流术可改善 ICP 升高的后遗症。